neostigmine has been researched along with Chromosomal Translocation in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Excerpt | Relevance | Reference |
---|---|---|
"This congenital myasthenic syndrome is for the first time associated with an autosomal translocation 2q31-9p27." | 1.31 | [Slow channel syndrome due to an autosomal translocation at 2q31-9p27]. ( Crielaard, JM; Hansen, I; Wang, FC; Zeevaert, B, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zeevaert, B | 1 |
Hansen, I | 1 |
Crielaard, JM | 1 |
Wang, FC | 1 |
1 other study available for neostigmine and Chromosomal Translocation
Article | Year |
---|---|
[Slow channel syndrome due to an autosomal translocation at 2q31-9p27].
Topics: Action Potentials; Adult; Autoimmune Diseases; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair | 2002 |